The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

Fri, 01st Dec 2023 07:41

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

According to Nationwide, the annual pace of decline in UK house prices eased somewhat in November, as house prices rose on a monthly basis.

"There has been a significant change in market expectations for the future path of bank rate in recent months which, if sustained, could provide much needed support for housing market activity," said Robert Gardner, Nationwide's chief economist.

So far on Friday morning, there have been manufacturing purchasing managers' index readings from China, Ireland and Japan. The economic calendar still has a slew of manufacturing PMI releases, including for the EU, Germany, the UK and the US.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.3% at 7,478.50

----------

Hang Seng: down 1.0% at 16,869.78

Nikkei 225: closed down 0.2% at 33,431.51

S&P/ASX 200: closed down 0.2% at 7,073.20

----------

DJIA: closed up 520.47 points, 1.5%, at 35,950.89

S&P 500: closed up 17.22 points, or 0.4%, at 4,567.80

Nasdaq Composite: closed down 32.27 points, or 0.2%, at 14,226.22

----------

EUR: up at USD1.0911 (USD1.0909)

GBP: down at USD1.2638 (USD1.2652)

USD: up at JPY148.22 (JPY147.85)

Gold: up at USD2,040.60 per ounce (USD2,038.85)

(Brent): up at USD80.61 a barrel (USD80.56)

(changes since previous London equities close)

----------

ECONOMICS

----------

Friday's key economic events still to come:

08:30 EST Canada labour force survey

09:30 EST Canada manufacturing PMI

10:00 CET EU manufacturing PMI

09:50 CET France manufacturing PMI

09:55 CET Germany manufacturing PMI

09:15 CET Spain manufacturing PMI

09:30 GMT UK manufacturing PMI

09:00 EST US Fed Chicago President Austan Goolsbee speaks

09:45 EST US S&P Global manufacturing PMI

10:00 EST US ISM manufacturing PMI

----------

The annual pace of decline in UK house prices eased somewhat in November, as house prices rose on a monthly basis, according to new data from Nationwide. On a seasonally adjusted basis, UK house prices rose by 0.2% in November from October, with growth slowing slightly from a 0.9% on-month rise in October. On an annual basis, prices were 2.0% lower in November, slowing from the 3.3% fall in October. The average house price, without seasonal adjustment, was GBP258,557 in November, down from GBP259,423 in October.

----------

A rise in new orders pushed China's factory sector back into growth in November, survey results from S&P Global showed. The Caixin manufacturing purchasing managers' index rose to a three-month high of 50.7 points last month from 49.5 in October. The reading above 50 points indicates growth in the sector. The Caixin PMI moved in the opposite direction from the same indicator issued by the National Bureau of Statistics on Thursday. Its manufacturing PMI reading for November was 49.4 points, still in contraction territory and slightly down from 49.5 in October. "Demand continued to grow, as the gauge for new orders remained in expansionary territory for the fourth consecutive month, hitting the highest since June," said Wang Zhe, senior economist at Caixin Insight Group. "Compared with consumer goods and intermediate goods, the supply and demand of investment goods were weaker.

----------

Manufacturing conditions in Japan continued to worsen in November, but performed better than initially indicated. The au Jibun manufacturing PMI fell to 48.3 points in November from 48.7 in October, but outperformed the flash estimate, and FXStreet-cited consensus, which were both at 48.1. Edging away from the 50 point mark separating expansion from contraction, the reading indicates an accelerated contraction in activity.

----------

A two-month decline in factory sector activity in Ireland was arrested in November, though only just barely, amid an improvement in production requirements, according to survey results released by S&P Global. Less positively, export orders declined for the third straight month. The AIB Ireland manufacturing PMI came in at 50.0 points in November, indicating neither growth nor decline. This was up from 48.2 points in October and 49.6 in September and was the second highest reading since February.

----------

BROKER RATING CHANGES

----------

UBS raises Antofagasta to 'buy' (neutral) - price target 1,700 (1,600) pence

----------

UBS raises Anglo American to 'buy' (neutral) - price target 2,500 pence

----------

Deutsche Bank cuts Pearson to 'hold' (buy) - price target 1,050 (1,100) pence

----------

COMPANIES - FTSE 100

----------

AstraZeneca has decided to discontinue the Stabilize-ckd and Dialize-Outcomes Phase III evidence trials for Lokelma, sodium zirconium cyclosilicate. The decision was made due to substantially increased enrolment timelines and low event rates, respectively, which made it prohibitive to deliver study results within a timeframe to meaningfully advance clinical practice. They are part of the Crystalize evidence programme, which researches the benefit of Lokelma in the management of hyperkalaemia across the cardiorenal spectrum.

----------

COMPANIES - FTSE 250

----------

3i Infrastructure said it has completed the sale of its 25% stake in Attero, a waste treatment and recycling companies in the Netherlands. The sale, to Ardian, was announced back in July. 3i will receive EUR215 million for the sale, which will be used to partially repay drawings on the company's revolving credit facility. Also, 3i said it has completed a further investment of GBP30 million in Future Biogas to fund the acquisition of two anaerobic digestion plants which are currently operated by Future Biogas.

----------

OTHER COMPANIES

----------

James Halstead updated shareholders ahead of its annual general meeting Friday. It said that whilst its "major markets face strong competition", it is seeing improved output and profits which are materially ahead of the comparatives. "We are confident of achieving full year market expectations of improved bottom line results and exceeding the half year comparatives, as well as extending our track record of increased dividends," Chair Anthony Wild said. "I and the board remain positive about the medium-term prospects for the group as a whole."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.